Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Hyperbaric Oxygen for Ischemic Diabetic Foot Ulcers?

Discussion in 'Diabetic Foot & Wound Management' started by Dieter Fellner, Feb 18, 2018.

  1. Dieter Fellner

    Dieter Fellner Well-Known Member


    Members do not see these Ads. Sign Up.
    https://www.jwatch.org/na45884/2018/01/23/hyperbaric-oxygen-ischemic-diabetic-foot-ulcers

    Allan S. Brett, MD reviewing Santema KTB et al. Diabetes Care 2018 Jan .

    This intervention did not improve outcomes in a randomized trial.

    Evidence about the effectiveness of hyperbaric oxygen therapy (HBOT) in patients with chronic ischemic leg ulcers is conflicting. In this trial from the Netherlands, 120 diabetic patients with ischemic foot ulcers were randomized to either standard care or standard care plus HBOT. All patients had evidence of limb ischemia (according to distal extremity blood pressures or low transcutaneous oxygen pressures), and patients who were candidates for revascularization underwent such procedures prior to starting HBOT. HBOT consisted of five 90-minute sessions weekly until healed (maximum sessions, 40).
    In intent-to-treat analyses at 12 months, the two groups did not differ significantly in incidences of complete wound healing, major amputation, or all-cause death. One third of patients in the HBOT group did not complete treatment. In a per-protocol analysis (in which only patients who received full HBOT courses were included in the HBOT group), the proportion of patients who underwent major amputation was significantly lower with HBOT than without it (5% vs. 22%).
     
Loading...

Share This Page